This meta-analytic review examines the ef.cacy of antipsychotic medications in ameliorating schizophrenia-related long-term memory (LTM) impairments. Twenty-three studies were reviewed that compared schizophrenia spectrum patients treated (a) with atypical versus typical antipsychotic medications, or (b) with various atypical treatments. In 17 atypical versus typical trials aggregating 939 participants, superior overall (verbal and nonverbal) LTM was detected in patients assigned to atypical trials. However, this difference was small (effect size estimate (ES) 0.17; 95% Con.dence Interval (CI) 0.04 to 0.31) and speci.c to certain atypical treatments. Relative to typical antipsychotic trials, LTM superiority was marginally signi.cant for risperidone trials (ES 0.20; 95% CI 0.03 to 0.44) and signi.cant for olanzapine trials (ES 0.29; 95% CI 0.08 to 0.49). In contrast, clozapine trials did not produce a LTM advantage over typical trials (ES 0.06; 95% CI 0.35 to 0.23). Due to the lack of available studies, the effect of quetiapine was indeterminate. Direct comparison between atypical trials revealed a similar effect pattern. A marginally signi.cant superiority in overall LTM was detected for risperidone and olanzapine compared to clozapine (ES 0.28; 95% CI 0.04 to 0.59), which reached signi.cance for verbal LTM (ES 0.36; 95% CI 0.04 to 0.67). Finally, the bene.cial impact of antipsychotic medications emerged as a function of differences in the anticholinergic properties of the treatment arms being compared.
Aleman A , Hijman R , de-Haan E H , Kahn R S (1999) Memory impairment in schizophrenia: a meta-analysis . Am J Psychiatry156: 1358–1366
2.
Bezchlibnyk-Butler K Z , Jeffries J J (1998) Clinical Handbook of Psychotherapeutic Drugs. Hogrefe and Huber, Seattle
3.
Bilder R M , Goldman R S , Volavka J , et al. (2002) Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder . Am J Psychiatry159: 1018–1028
4.
Borenstein M , Rothstein H (1999) Comprehensive Meta-Analysis. Biostat, Englewood, NJ
5.
Brebion G , Bressan R A , Amador X , Malaspina D , Gorman J M (2004) Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs . Psychol Med34: 369–374
6.
Buchanan R W , Holstein C , Breier A (1994) The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance . Biol Psychiatry36: 717–725
7.
Butters N , Delis D (1995) Clinical assessment of memory disorders in amnesia and dementia . Annu Rev Psychol46: 493–523
8.
Carpenter W T , Gold J M (2002) Another view of therapy for cognition in schizophrenia . Biol Psychiatry51: 969–971
9.
Chelune G J , Naugle R I , Lüders H , Sedlak J , Awad I A (1993) Individual change after epilepsy surgery: practice effects and base-rate information . Neuropsychology7: 41–52
10.
Cohen J (1988) Statistical Power Analysis for the Behavioral Sciences. Lawrence Earlbaum, Hillsdale, NJ
11.
Cohen N , Squire L (1981) Retrograde amnesia and remote memory impairment . Neuropsychologia19: 337–356
12.
Cuesta M J , Peralta V , Zarzuela A (2001) Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study . Schizophr Res48: 17–28
13.
Daniel D G , Goldberg T E , Weinberger D R , Kleinmann J E , Picker D , Lubick L J , Williams T S (1996) Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study . Am J Psychiatry153: 417–419
14.
Earnst K S , Taylor S F , Goldman R S , Tandon R (1999) The effects of typical antipsychotics, clozapine, and risperidone on neuropsychological test performance in schizophrenia . Schizophr Res40: 255–256
15.
Fennig S , Mottes A , Ricter-Levin G , Treves I , Levkovitz Y (2002) Everyday memory and laboratory memory tests: general function predictors in schizpohrenia and remitted depression . J Nerv Ment Dis190: 677–682
16.
Geddes J , Freemantle N , Harrison P , Bebbington P (2000) Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis . Br Med J321: 1371–1376
17.
Glass G V , McGaw B , Smith M L (1981) Meta-Analysis in Social Research. Sage, Newbury Park, CA
18.
Gold P E (2003) Acetylcholine modulation of neural systems involved in learning and memory . Neurobiol Learn Mem80: 194–210
19.
Green M F (1996) What are the functional consequences of neurocognitive deficits in schizophrenia?Am J Psychiatry153: 321–330
20.
Green M F (2000) Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the ‘right stuff’?Schizophr Bull26: 119–136
21.
Green M F , Marder S R , Glynn S M , McGurk S R , Wirshing W C , Wirshing D A , Liberman R P , Mintz J (2002) The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone . Biol Psychiatry51: 972–978
22.
Harvey P D , Green M F , McGurk S R , Meltzer H Y (2003a) Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study . Psychopharmacology (Berl)169: 404–411
23.
Harvey P D , Keefe R S (2001) Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatement . Am J Psychiatry158: 176–184
24.
Harvey P D , Napolitano J A , Mao L , Gharabawi G (2003b) Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder . Int J Geriatr Psychiatry18: 820–829
25.
Hawkins K A , Wexler B E (1999) California Verbal Learning Test practice effects in a schizophrenia sample . Schizophr Res39: 73–78
26.
Hedges L V , Olkin I (1985) Statistical Methods for Meta-Analysis. Academic Press, New York
27.
Heinrichs R W , Zakzanis K K (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence . Neuropsychology12: 426–445
28.
Keefe R S , Seidman L J , Christensen B K , Hamer R M , Sharma T , Sitskoorn M M , Lewine R R J , Yurgelun-todd D A , Gur R C , Tohen M , Tollefson G D , Sanger T M , Leiberman J A (2004) Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol . Am J Psychiatry161: 985–995
29.
Keefe R S E , Silva S G , Perkins D O , Lieberman J A (1999) The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis . Schizophr Bull25: 201–222
30.
Kern R S , Green M F , Marshall B D J , et al. (1999) Risperidone versus haloperidol on secondary memory: Can newer medications aid learning?Schizophr Bull2: 223–232
31.
Lee M A , Jayathilake K , Meltzer H Y (1999) A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia . Schizophr Res37: 1–11
32.
Lindenmayer J P , Iskandera , Park M , et al.(1998) Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study . J Clin Psychiatry59: 521–527
33.
Lineweaver T L , Chelune, G J (2003) Use of the WAIS-III and WMS-III in the context of serial assessments: interpreting reliable and meaningful change. In Tulsky D S , Saklofske D H , Chelune G J , Heaton R K , Ivnik R J , Bornstein R , Prifitera A , Ledbetter M F (eds), Clinical Interpretation of the WAIS-III and WMS-III. Academic Press, Amsterdam , pp. 303–337
34.
Meltzer H Y , McGurk S R (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia . Schizophr Bull25: 233–255
35.
Milas D Z , Ljubin T , Mimica N , Folnegovic-Smalc V , Makaric G (1999) Some memory span functions and motor speed in schizophrenics treated with olanzapine versus fluphenazine . Psychiatria Danubina11: 55–59
36.
Minzenberg M J , Poole J H , Benton C , Vinogradov S (2004) Association of anticholinergic load with impairment of complex attention and memory in schizophrenia . Am J Psychiatry161: 116–124
37.
Nieman D H , Koelman J H T M , Linzen D H , Bour L J , Dingemans P M , Ongerboer de Visser B W (2002) Clinical and neuropsychological correlates of the P300 in schizophrenia . Schizophr Res55: 105–113
38.
Potkin S G , Fleming K , Jin Y , Gulasekram B (2001) Clozapine enhances neurocognition and clinical symptomology more than standard neuroleptics . J Clin Psychopharmacol21: 479–483
39.
Purdon S E , Jones B D W , Stip E , Labelle A , Addington D , David S R , Breier A , Tollefson G D (2000) Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol . Arch Gen Psychiatry57: 249–258
40.
Purdon S E , Malla A , Labelle A , Lit W (2001) Neuropsychological changes in patients with schizophrenia after treatment with questiapine or haloperidol . J Psychiatry Neurosci26: 137–149
41.
Rollnik J D , Borsutzky M , Huber T J , Mogk H , Seifert J , Emrich H M , Schneider U (2002) Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics . Neuropsychobiology45: 74–80
42.
Rosenheck R , Perlick D , Bingham S , Lin-Mares W , Collins J , Warren S , Leslie D , Allan E , Campbell E C , Caroff S , Corwin J , Davis L , Douyou R , Dunn L , Evans D , Frecska E , Grabowski J , Graeber D , Herz L , Kwon K , Lawson W , Mena F , Sheikh J , Smelson D , Smith-Gamble V (2003) Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial . JAMA290: 2693–2702
43.
Sharma T , Hughes C , Soni W , Kumari V (2003) Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia . Psychopharmacology (Berl)169: 398–403
44.
Sweeney J A , Keilp J G , Haas G L , Hill J , Weiden P J (1991) Relationships between medication treatments and neuropsychological test performance in schizophrenia . Psychiatry Res37: 297–308
45.
Thiel C M (2003) Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging . Neurobiol Learn Mem80: 234–244
46.
Velligan D I , Miller A L (1999) Cognitive dysfunction in schizophrenia and its importance to outcome: the place of atypical antipsychotics in treatment . J Clin Psychiatry60: 25–28
47.
Velligan D I , Newcomer J , Pultz J , et al.(2002) Does cognitive function improve with quetiapine in comparison to haloperidol?Schizophr Res53: 239–248
48.
Velligan D I , Prihoda T J , Sui D , Ritch J L , Maples N , Miller A L (2003) The effectiveness of quetiapine versus conventional antipsychotics in improving cognitive and functional outcomes in standard treatment settings . J Clin Psychiatry64: 524–531
49.
Weiser M , Schneider-Beeri M , Nakash N , et al.(2000) Improvement in cognition associated with novel antipsychotic drugs: A direct drug effect or reduction of EPS?Schizophr Res46: 81–90
